ArticleJournal of health care for the poor and underserved2017
Antiretroviral Therapy: Racial Disparities among Publicly Insured Californians with HIV.
Article in Journal of health care for the poor and underserved, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Explaining inequity in knowledge, attitude, and services related to HIV/AIDS: a systematic review.BMC public health · 2024Pooled it
- The effect of a combined mHealth and community health worker intervention on HIV self-management.Journal of the American Medical Informatics Association : JAMIA · 2025Trial
- Kaposi sarcoma incidence and mortality trends and disparities in the United States.Infectious agents and cancer · 2025Article
- Social Determinants of ART Adherence among Black Adults with HIV.Research square · 2025Article
- The Use of HIV Prevention Strategies and Services Reported by Black Women with a Risk for and with HIV in the United States.AIDS and behavior · 2025Article
- Trends and disparities in antiretroviral therapy prescription rates among US Medicare beneficiaries with HIV.HIV medicine · 2025Article
- Antiretroviral Therapy Use and Disparities Among Medicare Beneficiaries with HIV.Journal of general internal medicine · 2024Observational
- Ongoing Healthcare Disparities in neuroHIV: Addressing Gaps in the Care Continuum.Current HIV/AIDS reports · 2023Review
- Universal Health Coverage for Antiretroviral Treatment: A Review.Infectious disease reports · 2022Review
- Availability of medical cannabis services by racial, social, and geographic characteristics of neighborhoods in New York: a cross-sectional study.BMC public health · 2022Article
- The Association Of HIV With Health Care Spending And Use Among Medicare Beneficiaries.Health affairs (Project Hope) · 2022Article
- Physician network connections to specialists and HIV quality of care.Health services research · 2021Article
- Sexually Transmitted Infection Testing of HIV-Positive Medicare and Medicaid Enrollees Falls Short of Guidelines.Sexually transmitted diseases · 2018Article
- Quality of Care for HIV/AIDS and for Primary Prevention by HIV Specialists and Nonspecialists.AIDS patient care and STDs · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Only 43% of Americans with HIV are virally suppressed; the rate is lower for African Americans, even among insured populations. This study uses 2010 Medicare and Medicaid data for HIV-positive Californians to examine how antiretroviral treatment (ART) relates to patient and provider characteristics. Logistic regressions isolated the effect of race/ethnicity on receipt of ART. Over 90% of the full sample received any ART. Nearly 80% of ART users received a recommended combination for at least half the year; half had a recommended combination for 90% of the year. Lacking evaluation and management visits, or seeing only providers with low HIV patient volume lowered the odds of receiving ART. Controlling for other factors, African Americans remained less likely to receive ART at all, or to be covered for 90% of the year with a recommended regimen. The observed racial treatment differentials may lead to important health disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.